Literature DB >> 33848698

An insight into the medicinal attributes of berberine derivatives: A review.

Sobhi Gaba1, Anjali Saini1, Gurpreet Singh1, Vikramdeep Monga2.   

Abstract

In the last few decades, traditional natural products have been the center of attention for the scientific community and exploration of their therapeutic abilities is proceeding perpetually. Berberine, with remarkable therapeutic diversity, is a plant derived isoquinoline alkaloid which is widely used as a traditional medicine in China. Berberine has been tackled as a fascinating pharmacophore to make great contributions to the discovery and development of new therapeutic agents against variegated diseases. Despite its tremendous therapeutic potential, clinical utility of this alkaloid was significantly compromised due to undesirable pharmacokinetic properties. To overcome this limitation, several structural modifications were performed on this scaffold to improve its therapeutic efficacy. The collective efforts of the community have achieved the tremendous advancements, bringing berberine to clinical use and discovering new therapeutic opportunities by structural modifications on the berberine scaffold. In this review, recent advancements in the medicinal chemistry of berberine and its derivatives in the last few years (2016-2020) have been compiled to represent inclusive data associated with various biological activities of this alkaloid. The comprehensive structure-activity relationship studies along with molecular modelling and mechanistic studies have also been summarized. This article would be highly helpful for the scientific community to get better insight into medicinal research of berberine and become a compelling guide for the rational design of berberine based compounds.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alkaloids; Anticancer; Antimicrobial; Berberine; Docking; Isoquinoline; Protoberberine

Year:  2021        PMID: 33848698     DOI: 10.1016/j.bmc.2021.116143

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  13 in total

1.  The natural product berberine synergizes with osimertinib preferentially against MET-amplified osimertinib-resistant lung cancer via direct MET inhibition.

Authors:  Zhen Chen; Karin A Vallega; Haiying Chen; Jia Zhou; Suresh S Ramalingam; Shi-Yong Sun
Journal:  Pharmacol Res       Date:  2021-11-24       Impact factor: 7.658

Review 2.  Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends.

Authors:  Tapan Behl; Sukhbir Singh; Neelam Sharma; Ishrat Zahoor; Ali Albarrati; Mohammed Albratty; Abdulkarim M Meraya; Asim Najmi; Simona Bungau
Journal:  Molecules       Date:  2022-06-09       Impact factor: 4.927

3.  Berberine Decreases Intestinal GLUT2 Translocation and Reduces Intestinal Glucose Absorption in Mice.

Authors:  Min Zhang; Hongyan Yang; Erwan Yang; Jia Li; Ling Dong
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

4.  Dissecting and Evaluating the Therapeutic Targets of Coptis Chinensis Franch in the Treatment of Urinary Tract Infections Induced by Escherichia coli.

Authors:  Zhenglin Chang; Jinhu Zhang; Min Lei; Zheng Jiang; Xiangkun Wu; Yapeng Huang; Zhican He; Yuyan Zhang; Shujue Li; Xiaolu Duan; Wenqi Wu
Journal:  Front Pharmacol       Date:  2022-01-12       Impact factor: 5.810

Review 5.  Mitochondrial Targeting Therapeutics: Promising Role of Natural Products in Non-alcoholic Fatty Liver Disease.

Authors:  Jingqi Xu; Jiayan Shen; Ruolan Yuan; Bona Jia; Yiwen Zhang; Sijian Wang; Yi Zhang; Mengyang Liu; Tao Wang
Journal:  Front Pharmacol       Date:  2021-12-23       Impact factor: 5.810

Review 6.  Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.

Authors:  Xiaopeng Ai; Peiling Yu; Lixia Peng; Liuling Luo; Jia Liu; Shengqian Li; Xianrong Lai; Fei Luan; Xianli Meng
Journal:  Front Pharmacol       Date:  2021-11-03       Impact factor: 5.810

7.  Design, Synthesis, Biological Evaluation and Silico Prediction of Novel Sinomenine Derivatives.

Authors:  Shoujie Li; Mingjie Gao; Xin Nian; Liyu Zhang; Jinjie Li; Dongmei Cui; Chen Zhang; Changqi Zhao
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

Review 8.  Berberine in Human Oncogenic Herpesvirus Infections and Their Linked Cancers.

Authors:  Miroslava Šudomová; Kateřina Berchová-Bímová; Stefania Marzocco; Alena Liskova; Peter Kubatka; Sherif T S Hassan
Journal:  Viruses       Date:  2021-05-28       Impact factor: 5.048

Review 9.  Bioactivity of Chitosan-Based Particles Loaded with Plant-Derived Extracts for Biomedical Applications: Emphasis on Antimicrobial Fiber-Based Systems.

Authors:  Joana C Antunes; Joana M Domingues; Catarina S Miranda; A Francisca G Silva; Natália C Homem; M Teresa P Amorim; Helena P Felgueiras
Journal:  Mar Drugs       Date:  2021-06-23       Impact factor: 5.118

10.  Discovery of the First in Class 9-N-Berberine Derivative as Hypoglycemic Agent with Extra-Strong Action.

Authors:  Mikhail V Khvostov; Elizaveta D Gladkova; Sergey A Borisov; Nataliya A Zhukova; Mariya K Marenina; Yuliya V Meshkova; Olga A Luzina; Tatijana G Tolstikova; Nariman F Salakhutdinov
Journal:  Pharmaceutics       Date:  2021-12-12       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.